News
Teriflunomide matched ocrelizumab in controlling smoldering RRMS activity and showed a possible advantage in preserving brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback